NO20081016L
(en )
2008-04-18
New 1-aryl-3-azabicyclo (3.1.0) hexanes, preparation and use for the treatment of neuropsychiatric disorders
AP2378A
(en )
2012-03-08
Sulfonamide derivatives for the treatment of diseases.
EP3311818A3
(en )
2018-07-18
Inhibitors of bruton's tyrosine kinase for the treatment of solid tumors
AP2359A
(en )
2012-01-30
Sulfonamide derivatives for the treatment of diseases.
LTC1830843I2
(en )
2017-03-10
Indolidone derivatives for the treatment or prevention of fibrotic diseases
NO20091700L
(en )
2009-06-16
Florizine analogues as inhibitors of glucose co-transporter 2
BR0215924B1
(en )
2012-08-21
device for osteosynthesis.
EP1838320A4
(en )
2009-03-18
Cxcr4 antagonists for the treatment of medical disorders
WO2007127505A3
(en )
2007-12-27
Use of sulfonamide derivatives in the treatment of disorders of the metabolism and the nervous system
ITRM20050446A1
(en )
2007-02-20
USE OF HYDROXYLATED AND GLUCOSIDATED STYLBENES FOR THE PREVENTION AND TREATMENT OF EYE PATHOLOGIES.
NO20055098D0
(en )
2005-11-01
Use of 10-hydroxy-10,11-dihydrocarbamazepine derivatives for the treatment of affective disorders
WO2007050793A3
(en )
2008-01-24
Methods and compositions for the treatment of marfan syndrome and associated disorders
WO2009071689A3
(en )
2009-07-23
5-halogen-substituted oxindole derivatives and use thereof for treating vasopressine-dependent diseases
WO2007051785A3
(en )
2007-09-07
Use of sdf-1 for the treatment and/or prevention of neurological diseases
ITRM20050179A1
(en )
2006-10-14
APPLICABLE COMPOSITION FOR THE TREATMENT OF PARADONTAL DISEASES.
DK1713438T3
(en )
2008-11-10
Medical soap
NO20054034D0
(en )
2005-08-30
Procedures for the treatment of hypothyroidism.
WO2007015173A3
(en )
2007-07-12
Inflammation
ITRM20040625A1
(en )
2005-03-21
CUSTOMIZED OCCLUSIVE PLATE FOR THE TREATMENT OF POSTURAL DISORDERS AND ITS PROCEDURE.
ITTO20030850A1
(en )
2005-04-30
PROCEDURE FOR THE PREPARATION OF 4-AMINO-3,5-DICLORO-BENZOTRIFLORURO.
NL1032065A1
(en )
2007-01-08
Preparation for the prevention and treatment of cardiovascular disorders.
WO2005107464A3
(en )
2006-06-08
Compounds and compositions as cathepsin s inhibitors
WO2005023253A8
(en )
2006-03-02
Use of pde4 inhibitors for the treatment of diabetes mellitus
DE602004020337D1
(en )
2009-05-14
Anticholinergic drugs for the treatment of urinary tract disorders
ITRM20040047A1
(en )
2004-04-27
Vaccine for the treatment of tuberculosis.